China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

Posted by Doug Wharley on Sep 15th, 2025

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Free Report) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 44,700 shares, a decrease of 40.6% from the August 15th total of 75,200 shares. Based on an average trading volume of 308,800 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 308,800 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised China SXT Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Saturday, August 2nd.

Read Our Latest Stock Report on China SXT Pharmaceuticals

China SXT Pharmaceuticals Trading Down 7.1%

NASDAQ:SXTC traded down $0.14 on Monday, reaching $1.84. 72,882 shares of the stock traded hands, compared to its average volume of 1,730,906. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.40 and a current ratio of 3.54. China SXT Pharmaceuticals has a 1-year low of $0.95 and a 1-year high of $7.84. The company’s 50 day moving average is $1.60 and its 200-day moving average is $2.02.

About China SXT Pharmaceuticals

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.